Cita APA

Giuntini, F. (2025). Omomyc as a novel therapeutic strategy against metastatic triple-negative breast cancer, alone and in combination with the standard of care.

Citación estilo Chicago

Giuntini, Fabio. Omomyc As a Novel Therapeutic Strategy against Metastatic Triple-negative Breast Cancer, Alone and in Combination With the Standard of Care. 2025.

Cita MLA

Giuntini, Fabio. Omomyc As a Novel Therapeutic Strategy against Metastatic Triple-negative Breast Cancer, Alone and in Combination With the Standard of Care. 2025.